CollPlant Biotechnologies (CLGN) Interest & Investment Income (2017 - 2021)
CollPlant Biotechnologies' (CLGN) quarterly Interest & Investment Income came in at -$188.8 million in Q4 2021, down 1013.1% YoY from $20.7 million in Q4 2020, and down 381.76% on a QoQ basis from $67.0 million in Q3 2021.
CollPlant Biotechnologies (CLGN) Interest & Investment Income (2017 - 2021) Analysis & Trends
CollPlant Biotechnologies (CLGN) has 5 years of Interest & Investment Income data on file, last reported at -$188.8 million in Q4 2021.
- Quarterly Interest & Investment Income fell 1013.1% year-over-year to -$188.8 million in Q4 2021, while the trailing twelve-month figure through Dec 2021 was -$121.7 million (down 304247.5% YoY) and the FY2025 annual result came in at $380000.0, down 48.51% from the prior year.
- Interest & Investment Income eased to -$188.8 million in Q4 2021, from $67.0 million in the prior quarter.
- In the past five years, Interest & Investment Income ranged from a high of $67.0 million in Q3 2021 to a low of -$188.8 million in Q4 2021.
- A 5-year average of -$8.1 million and a median of $9000.0 in 2020 frame the typical range for Interest & Investment Income.
- Annual changes were most pronounced in 2019 — Interest & Investment Income jumped 1440.43% — and 2021, when it tumbled 1013.1%.
- Tracing CLGN's Interest & Investment Income over 5 years: stood at -$81000.0 in 2017, then surged by 666.67% to $459000.0 in 2018, then jumped by 37.25% to $630000.0 in 2019, then slumped by 2792.06% to -$17.0 million in 2020, then plunged by 1013.1% to -$188.8 million in 2021.
- The last three Interest & Investment Income figures came in at -$188.8 million (Q4 2021), $67.0 million (Q3 2021), and $72000.0 (Q2 2021), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Int & Inv Inc (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | 120.60 Mn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | -48.00 Mn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | 48.00 Mn |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | 67.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | 27.90 Mn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | 28.14 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | 115.94 Mn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | 10.98 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | 5.13 Mn |
| 10 | CollPlant Biotechnologies | 4.26 Mn | 4.26 Mn | -243,000.00 | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2021 | -188.78 Mn |
| Sep 30, 2021 | 67.00 Mn |
| Jun 30, 2021 | 72,000.00 |
| Mar 31, 2021 | 50,000.00 |
| Dec 31, 2020 | -16.96 Mn |
| Sep 30, 2020 | 16.97 Mn |
| Jun 30, 2020 | 9,000.00 |
| Mar 31, 2020 | 17,000.00 |
| Jun 30, 2019 | 630,000.00 |
| Mar 31, 2019 | -16,000.00 |
| Dec 31, 2018 | 459,000.00 |
| Sep 30, 2018 | -106,000.00 |
| Jun 30, 2018 | -47,000.00 |
| Mar 31, 2018 | -112,000.00 |
| Dec 31, 2017 | -81,000.00 |